Investor Relations
30
2025.12
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
30
2025.12
ANNOUNCEMENT - (1) COMPLETION OF VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER; (3) THE ONE-OFF SHARE OPTION PLAN; (4) CHANGE OF COMPANY NAME; (5) REMOVAL OF STOCK MARKER; (6) CHANGE IN THE COMPOSITION OF THE BOARD; (7) CHANGE OF AUTHORISED REPRESENTATIVES AND AGENT FOR THE SERVICES OF PROCESS IN HONG KONG; (8) CHANGE OF JOINT COMPANY SECRETARIES AND (9)CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
22
2025.12
DIS-APPLICATION OF RULES 18A.09 TO 18A.11 OF THE LISTING RULES
22
2025.12
ANNOUNCEMENT ON (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 22 DECEMBER 2025; (2) GRANT OF WHITEWASH WAIVER AND CONSENT TO SPECIAL DEAL; AND (3) INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY
08
2025.12
VOLUNTARY ANNOUNCEMENT - THE INCLUSION OF LEROCICLIB (GB491) IN CHINA'S NATIONAL REIMBURSEMENT DRUG LIST
04
2025.12
(1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND DESPATCH OF CIRCULAR
04
2025.12
CLOSURE OF REGISTER OF MEMBERS
04
2025.12
DOCUMENTS ON DISPLAY
04
2025.12
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD AT ROOM 501-02, 5/F, BUILDING 6, 690 BIBO ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA ON MONDAY, 22 DECEMBER 2025 AT 10:00 A.M.
04
2025.12
NOTICE OF EXTRAORDINARY GENERAL MEETING
04
2025.12
(1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL IN RELATION TO THE RETENTION PLAN OF THE SHAREHOLDER PERSONNEL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND (8) NOTICE OF EGM
30
2025.12
List of Directors and Their Roles and Functions
30
2025.12
Terms of Reference of the Audit Committee
30
2025.12
Terms of Reference of the Compensation Committee
30
2025.12
Terms of Reference of the Nomination Committee
30
2025.12
Procedures for Shareholders to Propose a Person for Election as a Director of the Company
30
2025.12
Shareholders' Communication Policy
Edding Genor Group Holdings Limited
Room 406, Building 1, No. 36 Doukou Road, Hengqin, Zhuhai,China
IR@eddingpharm.com